The influenza virus M2 protein was expressed from a recombinant baculovirus in Spodoptera frugiperda Sf9 cells, purified and reconstituted into artificial membrane vesicles. The specific inhibitor amantadine overcame the toxic activity of the protein and boosted the rate of M2 synthesis by a factor of 10, allowing yields of about 1 mg of purified M2 protein per g of Sf9 cells. M2 protein expressed in this system was phosphorylated and palmitoylated and displayed properties similar to the authentic virus protein. Purified wild-type M2 protein and an amantadine-resistant mutant M2 (M26) with a deletion in the trans-membrane domain (amino acids 28 to 31) were incorporated into lipid vesicles, which were loaded with the fluorescent pH indicator pyranine. On imposition of an ionic gradient, M2 caused a decrease in intravesicular pH, which was susceptible to inhibition by 0.1 to 1 gM-rimantadine or N-ethylrimantadine. M26 behaved similarly but exhibited the expected drug resistance. These experiments indicate that isolated M2 functions as an ion channel and demonstrates in vitro M2-mediated proton translocation.
Introduction
The influenza virus M2 protein is a minor virus envelope protein expressed from a spliced mRNA encoded by the M gene (Lamb & Choppin, 1981) . The 96 amino acid polypeptides associate to form disulphide-linked homotetramers Holsinger & Lamb, 1991) which are modified by the addition of palmitate and phosphate (Sugrue et al., 1990b; Veit et al., 1991) . As the target of the antiviral compounds amantadine and rimantadine (Hay et al., 1985) M2 was implicated in virus uncoating (Kato & Eggers, 1969; Bukrinskaya et al,, 1982; Wharton et al., 1990; Martin & Helenins, 1991) . More recently, it has been proposed that during endocytosis the M2 ion channel is responsible for allowing the passage of protons from the acid endosome into the virion, thereby promoting a low pH-induced dissociation of the matrix protein from the nucleocapsid (Hay, 1989; Wharton et al., 1990) . Such a role of M2 would be analogous to its ability to reduce the acidity of the trans Golgi network and thereby protect intracellularly cleaved haemagglutinin (HA) against a premature low pH-induced conformational alteration during t Present address: Institut ffir Virologie, Medizinische Fakultfit (Charit6) der Humboldt-Universit/it zu Berlin, Schumannstrasse 20/21, 10098 Berlin, Germany, :~ Present address: Waite Agricultural Research Institute, The University of Adelaide, Glen Osmond, South Australia 5064. transport to the plasma membrane (Sugrue et al., 1990a; Ciampor et al., 1992a; Takeuchi & Lamb, 1994; Ohuchi et al., 1994) .
Using the conformation of HA as a probe to monitor the pH modulating activity of M2 in infected cells it was estimated that M2 elevates the pH of trans Golgi vesicles by up to 0.8 pH units . Mutations in M2 that confer resistance to amantadine may either enhance or reduce the pH-modulating activity of the protein and M2 proteins with a higher intrinsic activity can complement less active M2 proteins in supporting the maturation of acid-labile HAs . The correlation between differences in the pH-modulating activity of M2 and differences in the pH stabilities of the respective HAs of certain influenza virus strains indicates the importance of compatibility between the two proteins. Furthermore, since the amantadine sensitivity of HA mutants increases with the acid lability of their HAs it has conversely been possible to select in the presence of amantadine a mutant with an acid-stable HA (Steinhauer et al., 1991) . The M2 protein in the plasma membrane can also counteract a trans-membrane pH gradient, reducing the intracellular pH to that of the outside medium (Ciampor et al., 1992b) .
Direct measurements of ion channel activity in voltageclamp experiments demonstrated that M2 expressed in Xenopus laevis oocytes possesses a pH-activated, Na +-selective conductance (Pinto et al., 1992; Wang et al., 1993) . Under the conditions used in these experiments it 0001-2621 © 1994 SGM was not possible to resolve proton currents. However, a peptide corresponding to the trans-membrane domain of M2 incorporated into planar lipid bilayers has been shown to promote amantadine-sensitive proton translocation at mitlimolar proton concentrations (Duff & Ashley, 1992) .
We report here the use of a fluorescent dye assay to demonstrate, under mild conditions, the proton translocation activity of purified M2 reconstituted into lipid vesicles. The M2 protein was expressed under the control of the baculovirus polyhedron promoter in Spodoptera frugiperda Sf9 cells. The proton translocation activity of the wild-type M2 protein was specifically inhibited by rimantadine whereas the activity of a drug-resistant mutant protein was unaffected.
Methods
Virus and cells. Wild-type Autographa cal!fornica multinucleocapsid nuclear polyhedrosis virus (AcMPNV; polyhedrin-positive) was obtained from Dr M. D. Summers (Texas A & M University, Tex., U.S.A.). BacPAK6 virus was a product of Clontech Laboratories. The St9 cell subline RE was provided by Dr H. Reil/inder (Max-PlanckInstitut f~r Membranbiophysik, Frankfurt, Germany). Trichoplusia ni cells (Hi5) were obtained from JRH Biosciences.
Sf9 cells were grown in TC100 medium (purchased from Gibco or Flow Laboratories) supplemented with L-glutamine (292 mg/l), fetal calf serum (FCS; 10%), penicillin (60 mg/l), streptomycin (100 mg/1) and in some cases, amphotericin (Flow Laboratories, 2.5 mg/1). Hi5 cells were grown in SF-900 II serum-free medium (Gibco). Cell cultivation, virus propagation and titration were carried out as described by Luckow & Summers (1989) .
Antisera. Rabbit antisera were raised against peptides corresponding to the N-terminal 24 amino acids (R7 and R53), to the C-terminal 16 amino acids (R54) and to amino acids 60 to 76 (R15) of the M2 protein of influenza virus strain A/chicken/Rostock/34 (H7N1).
lnhibitors. All compounds were in the form of hydrochlorides. Amantadine was a product of Serva, rimantadine was a gift from Dr I. Sire (Hoffmann-La Roche) and N-ethylrimantadine was provided by Dr M. K. Indulen (August Kirchenstein Institute of Microbiology, Latvian Academy of Sciences, Riga, Latvia).
Construction of baculovirus recombinants. The plasmid pVL941 (Luckow & Summers, 1989) was obtained from Dr M. D. Summers. An EcoRI-Sall fragment encompassing the M2 sequence of influenza virus A/Weybridge (H7N7) was converted to a BamHI fragment by attaching appropriate linkers and inserted into the BamHI site of pVL941, generating the recombinant pVLM2. This plasmid was cotransfected with AcMNPV wild-type DNA into Sf9 cells using Lipofectin from BRL (Felgner et al., 1987) . Polyhedrin-negative plaques were picked and M2-producing clones were plaque-purified. The M2-expressing recombinant baculovirus used was designated CFM2.
A deletion mutant of M2 (lacking amino acids 28 to 31) was constructed by PCR mutagenesis of pVLM2. Primers complementary to the sequences flanking the intended deletion were extended with Vent polymerase (New England Biolabs). The product was phosphorylated with T4 polynucleotide kinase (Boehringer Mannheim), ligated with T4 DNA ligase (New England Biolabs) and used to transform competent Escheriehia coli DH5 cells. Mutant plasmid DNA and Bsu36I-linearized BacPAK6 DNA (Kitts et al., 1990) )] and cells were incubated for 30rain or l h. Monolayers were then washed and incubated at 27 °C with chase medium (1 ml TC100 plus 10% FCS). Finally, monolayers were washed with ice-cold PBS pH 6-6, and extracted with 100 lal of 1% NP40 in 150 mM-NaCl, 20 mM-Tris HCI pH 7-5 for 10 min at 4 °C. For immune precipitation the extract was diluted into 12 volumes of binding buffer (0.5 % NP40, 150 mM-NaC1, 1 mM-EDTA, 0-25 % BSA, 20 mM-Tris-HCt pH 8.0) containing anti-M2 antiserum (1:100) and precipitated with protein A Sepharose (Pharmacia), as described by Sugrue et al. (1990b) .
Purification of M2 protein.
Suspension cultures of exponentially growing Sf9 cells (10n/ml) were concentrated by centrifugation and infected with baculovirus CFM2 at a m.o.i, of 2 p.f.u./cell. After a 1 h adsorption period the cells were taken up in fresh medium containing 1 gg/ml amantadine and cultured for 48 h at 27 °C. The cells (2 to 5 g per 1 of cell culture) were harvested, washed three times in HEPESbuffered saline (HBS; 10mM-HEPES, 150mM-NaC1 pH7-8), and taken up in 10 volumes of ice-cold 10 mM-HEPES pH 7-8 supplemented with 1 mM-PMSF, 0.02% trypsin inhibitor (soybean) and 10 p,g/ml aprotinin (all from Sigma). This protease inhibitor combination was used until the KCI extraction step. The cells were disrupted in a Dounce homogenizer and the nuclei and remaining intact cells were pelleted. The supernatant was made 70% (w/v) in sucrose, overlaid with HBS pH 7.8 and centrifuged for 12 h at 20000 r.p.m, in a Beckman SW-28 rotor. The membrane fraction at the interface was pelleted at 26000 r.p.m, for 90 min, washed once in HBS pH 7.8, and extracted with 1 M-KC1 in HBS pH 7.8 for 1 h at 4 °C. The membrane pellet was washed once in HBS pH 7.8 containing a mixture of low M r protease inhibitors [1 mM-PMSF, 10 gM-E-64 (trans-epoxysuccinyl-L-leucylamido(4-guanidino)-butane), 1 gM-bestatin, 1 laM-pepstatin A (Sigma)], which was used throughout the following purification steps except immunoaffinity chromatography. The membranes were extracted for l h at 4°C with 4mra-n-octyl glucoside (OG; 1-O-n-octyl fl-Dglucopyranoside; Sigma), pelleted once more as above, and finally M2 was extracted with 40 mM-OG for 1 h at 4 °C.
M2 protein was purified either directly using an immunoaffinity column, or by Phosphogel (Pierce) followed by immunoaffinity chromatography. After application to activated Phosphogel at pH 4.0 the column was washed with 100 raM-sodium acetate pH 4.0 containing 40 mM-OG and eluted with 20 mM-NaH2PO 4 or Na2HPO 4 pH 7-0 and 40 mM-OG. M2-containing fractions were pooled and the buffer was exchanged for HBS pH 7.0 containing 40 mM-OG. The concentrate was applied to an immunoaNnity column [Affi-Gel Hz (Bio-Rad) to which was coupled immunoglobulin purified from R53 serum]. Th~ colt~mn was washed with HBS pH 7.0 and 40 mM-OG, and eluted in 1 ml fractions with 100mM-glycine-HCl pH2.8 and 40mr~0G. The fractions were immediately neutralized, M2-containing fractfons were pooled and concentrated and the buffer was exchanged for HBS pH 7.0 with 40 mM-OG.
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The M2 deletion protein (M2J) was purified from 1 1 of Hi5 cells infected with CSM26. The 40 mM-OG extract was applied directly to a freshly prepared immunoaffinity column.
Protein detection. The concentration of M2 in semipure and purified preparations was estimated from the A280 measurement using the formula of Beaven & Holiday (1952) . Concentration estimates took into account the level of impurities as detected by silver staining. Estimates of M2 concentrations in membrane and cell extracts were made on the basis of Western blots of purified and crude samples run in parallel on polyacrylamide gels.
Gel electrophoresis and Western blotting. Samples in 2 x Laemmli buffer were boiled for 2 min in the presence or absence of 50 mM-DTT and run on 12% or 10% polyacrylamide gels with [14C]methylated Rainbow markers (Amersham) as M r standards. Gels were processed for fluorography by immersing in Amplify (Amersham) or Westernblotted on Immobilon P membranes (Millipore). Blots were blocked overnight in 1% dried skimmed milk in PBS, treated with primary antibodies (diluted 1 : 500) for 2 h, washed five times, then treated for 1 h with iodinated donkey anti-rabbit antibody (Amersham) diluted 1 : 1000 into 1% skimmed milk in PBS. Blots and Amplify-treated gels were dried and exposed to pre-flashed X-ray film at -70 °C.
Reconstitution into lipid vesicles. M2 was reconstituted into liposomes based on procedures of Ruigrok et al. (1986) and Dencher et al. (1986) • A solution containing 0-85 mg of L-c~-dimyristoyl phosphatidylcholine (DMPC; Sigma), 0•15mg L-c~-phosphatidyl e-serine (Sigma) and 0.7 mol % (with respect to lipids) valinomycin in chloroform methanol (95 : 5 v/v) in a glass tube was evaporated to a thin film under a stream of argon, dried under vacuum overnight and taken up in 250 lal of potassium phosphate buffer (10 mM-K2HPO4, 50 mM-K~SO4) pH 7.4, supplemented with 40 mM-OG, with or without 50 lag of M2 or M26 protein. The molar ratio of lipid to protein was 250. Vesicles were formed by sequential dialysis against increasing volumes of the same buffer (Ruigrok et al., 1986) containing 0.04 % sodium azide. The azide was omitted and amberlite XAD-2 was included in the final dialysis buffer.
Fluorescence assay of intravesieular pH. Vesicles were loaded with 2 mM-pyranine (Molecular Probes) by sonication (3 x 10 s in a bath sonicator). Excess dye was removed by dialysis or by passage through a column of superfine Sephadex G50 (Pharmacia). 5 mg/ml DPX (pxylene-bis-pyridinium bromide; Molecular Probes) was included in the assay buffer to quench fluorescence of residual surface-bound dye. Intravesicular pH was calculated from the ratio of the emission intensities at 510 nm for the two excitation wavelengths 403 and 460 nm, as described by Dencher et al. (1986) . A calibration plot was derived from the emission ratios of pyranine in buffers of varying pH. Vesicles and reaction buffers were preincubated at 12 °C. Reactions were run at 12 °C in a Shimadzu PC5001 fluorimeter using the double wavelength recording mode. Readings were taken every 10 s for 290 to 360 s. The reaction was started by adding a 10 lal vesicle suspension to 600 lal of sodium buffer (10 mM-Na2HPO4, 50 mM-Na2SO 4 pH 7.4) in a fluorescence cuvette. A mixture of valinomycin (5 laM) and nigericin (10 laM) was added to equilibrate the pH gradient (Pressman, 1976) . Initial slopes of ratio plots were calculated from the difference in the intensity ratios at 60 s and 10 s after starting the reaction, divided by 50.
Results

Effects of amantadine on M2 expression in SJ9 cells
During initial experiments it became clear that laboratory variants of the Sf9 cell line differed in their sensitivity to toxicity caused by the M2 protein expressed by the recombinant baculovirus CFM2. The most resilient Sf9 line, RE, was selected for the production of M2 (Fig. 1) . Later in the course of this work a 'high producer' insect cell line, T. ni Hi5, which was superior to Sf9 RE (Fig. 1 a, b ) became available and was used to produce the amantadine-resistant mutant M2 protein, M2J (Fig. 1 c) . Expression of the wild-type M2 protein was not enhanced appreciably by increasing the m.o.i. above 2. Incubation in the presence of 1 gg/ml amantadine, however, increased synthesis of M2 by about 10-fold whether assessed by [3SS]cysteine incorporation or by Western blot analysis (Fig. 1 a, b) . The expression of the amantadine-resistant deletion (amino acids 28 to 31) mutant M26 (Hay et al., 1985) was not susceptible to amantadine stimulation (data not shown)• However, in Hi5 cells the level of M26 expression was comparable to that of wild-type M2 in the presence of amantadine (Fig.  1 c) .
Characteristics o f M 2
Influenza virus M2 protein is a palmitoylated phosphoprotein (Sugrue et al., 1990b; Fig. 2 a, lanes 6 to 8) and palmitoylated (Fig. 2 a,  lanes 2 and 3) . The M2 monomer appeared as a doublet 
(2) ~ .... ( Fig. 2a, lane 4 
), since a p r o p o r t i o n o f the p a l m i t a t e is lost d u r i n g boiling a n d reduction. T h e b a n d of lower m o b i l i t y c o n t a i n s the p a l m i t o y l a t e d species (Sugrue et al., 1990b).
A n a l y s e s o f M 2 synthesized in r e c o m b i n a n t b a c u l ovirus-infected Sf9 cells showed the presence of m o n o m e r s (Fig. 2a) , dimers, trimers a n d tetramers (Fig. 2b) , as for the M 2 synthesized in influenza virus-infected cells. I n pure a n d relatively c o n c e n t r a t e d M 2 p r e p a r a t i o n s (200 g g / m l ) high M r species, o f a p p r o x i m a t e l y 200K, p r e d o m i n a t e d (Fig. 3c) ; similar b a n d s have b e e n observed in analyses o f influenza virus virion proteins. By several criteria, therefore, M 2 expressed f r o m rec o m b i n a n t b a c u l o v i r u s in Sf9 cells resembled the a u t hentic influenza virus protein. A detergent extract (60 ml) from CFM2-infected Sf9 cells was applied to an immunoaffinity column. After washing, 1 ml fractions were eluted as described in Methods and 10 gl samples were applied to 12% polyacrylamide gels. One gel was silver-stained (a) and the other blotted for 30 rain (b) and reblotted for another 90 rain (c). Lane i, detergent extract input; lane u, unbound material; lanes 1 to 7, fraction numbers; lane 3", unreduced fraction 3. By OD measurements, sample 3 was found to contain 0.9 ~g protein.
Purification of M2 protein
M 2 p r o t e i n was purified f r o m Sf9 R E cells as described in M e t h o d s . T h e m e m b r a n e fraction was treated with 1 M-KC1 a n d 4 m M -O G to r e m o v e p e r i p h e r a l p r o t e i n s a n d the M 2 p r o t e i n was extracted q u a n t i t a t (Fig. 3a) as monomers, dimers and tetramers is made on the basis of bands at equivalent positions in a parallel gel (Fig. 3 b, c) . Most of the monomer transferred within 30 min (Fig. 3 b) while the tetramer and the high M r (> 200K) species in the unreduced, unboiled sample (3") of fraction 3 transferred more slowly (Fig. 3 c) .
In larger scale preparations the detergent extract was enriched for phosphoproteins using a column of immobilized Fe 3+ ions (Phosphogel) before immunoaffinity chromatography.
Proton translocation activity of M2 protein in lipid vesicles
We examined the suitability of various lipid mixtures and reconstitution techniques for producing M2 vesicles in which ion translocation activity could be assayed. The following method was established: detergent solutions of M2 (purified by Phosphogel followed by immunoaffinity chromatography) and M2O (immunoaffinity-purified) were reconstituted with a mixture of DMPC, phosphatidyl serine and valinomycin (0-7 tool % with respect Fig. 4 as described in Methods.
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to lipids) in a potassium phosphate buffer containing K + as the only cation. OG was removed by extensive dialysis. Control vesicles without protein were prepared in parallel. The vesicles were loaded with 2 mu-pyranine (a fluorescent pH indicator; Dencher et al., 1986) and fluorescence caused by residual externally bound dye was quenched by DPX. The driving force for proton flux across a membrane can either be a pH gradient or a membrane potential (Garcia et al., 1984) . The incorporation of valinomycin in the membrane of K+-containing vesicles allowed the creation of a diffusion potential on exposure of these vesicles to the sodium buffer. The internal pH was monitored by recording, every 10 s, emission intensities at 510nm for two excitation wavelengths, 403 and 460 nm ( Fig. 4 ; Dencher et al., 1986) . Reactions were terminated by adding an excess of the K+/H + ionophore nigericin together with the K + ionophore valinomycin to collapse the proton gradient. This elicited an unexplained transient (10 s) drop in pH in the control vesicles before pH equilibration.
After introducing the vesicles into the sodium buffer, proton influx into M2-and M2g-containing vesicles was initially rapid and the pH reached an equilibrium within 4 min (Fig. 4b, c) . The plot resembles a saturation curve. Initial acidification rates, represented by the slopes, were calculated as described in Methods and are shown in Table 1 . The internal pH of M2 and M2g vesicles, determined using a calibration plot, decreased by about 0.5 units (Fig. 4b, c) . Under the same conditions the pH in the control vesicles (Fig. 4a) exhibited a slow linear decrease of 0.06 units over 5 min and did not reach equilibrium. In the presence of rimantadine the pH decreased more rapidly, at 1 jam by 0"19 units and at 10 JaM by 0"33 units, indicating that the drug itself promoted detectable vesicle acidification (Fig. 4a) .
Both the initial acidification rate and the equilibrium pH of M2-containing vesicles were influenced by inhibitors of M2. However, only the initial rates were obtained under identical ionic conditions. Rimantadine at 0"1 and 1 jaM inhibited the acidification of M2 vesicles to a similar extent whereas 10 jaM-rimantadine enhanced acidification ( Fig. 4b; Table 1 ). Exactly the same effects of rimantadine (inhibitory at 1 jaM but stimulatory at 10 jaM) were observed when the reaction was not terminated with ionophores but instead was re-initiated by addition of H3PO4, lowering the external pH by about 1 unit and thereby causing a further decrease in the internal pH until a new equilibrium was reached (data not shown).
N-ethylrimantadine causes a similar degree of inhibition of influenza virus infection as rimantadine (Indulen et al., 1979) . 0"67jaM-N-ethylrimantadine caused a somewhat greater reduction (2.3-fold) in the initial rate of the pH change in M2-containing vesicles than did 1 jaM-rimantadine (l'8-fold). Stimulatory concentrations (10 jaM) of both compounds increased the rate 1.2-fold ( Fig. 4b ; Table 1 ).
M26-containing vesicles responded differently to these inhibitors. Acidification proceeded similarly in the absence and in the presence of rimantadine or Nethylrimantadine ( Fig. 4c; Table 1 ), consistent with the drug resistance of the protein. However, 1 jaM-rimantadine, but not 0-67 jaM-N-ethylrimantadine, clearly elevated the equilibrium pH (Fig. 4c) , although the initial rate was only slightly reduced; 1.1-fold as compared to 1.8-fold in the case of wild-type M2-containing vesicles (Table 1) . The reason for this is not clear.
Discussion
The baculovirus-Sf9 cell expression system was chosen to produce the M2 protein since it has been successfully exploited for the other influenza virus envelope proteins (Kuroda et al., 1986; Weyer & Possee, 1991) as well as for ion channel proteins (e.g. Kamb et al., 1992; Carter et al., 1992) . M2 expressed by the recombinant baculovirus resembled the authentic virus protein in that it was phosphorylated and palmitoylated and formed homotetramers Sugrue et al., 1990b; Veit et al., 1991 ; Holsinger & Lamb, 1991) . In pure and relatively concentrated preparations very large M2 complexes were observed, the functional significance of which is not known. Under optimum conditions the yield per I of Sf9 cell suspension was 2 to 4 mg of M2 protein, of which about 50 % was recovered in purified form. Two-to threefold higher yields were obtained using Hi5 cells.
The alleviation of M2 toxicity to the insect cells by amantadine was due to inhibition of M2 function, since the drug enhanced M2 synthesis about 10-fold. Black et al. (1993) reported a similar drug-induced enhancement of the expression of the M2 protein of influenza virus strain A/Ann Arbor/6/60, which differs from the Weybridge strain M2 by 15 amino acids (Ito et al., 1991) . In contrast, amantadine treatment has no effect on M2 synthesis in virus-infected cells or M2 expression in mammalian cells or E. coli (F. Geraghty, A. Hayhurst & A. Hay, unpublished results) . Thus, the effect appears to result from M2 activity on the one hand and properties of the baculovirus-insect cell system on the other. M2 in the plasma membrane of mammalian cells can dissipate a pH gradient between extra-and intracellular environments, causing a decrease in cytoplasmic pH (Ciampor et al., 1992b) . The pH of the insect cell medium is particularly low (pH 6.2 to 6-4); thus changes in the internal ionic environment may well underlie the distinctive M2-related phenomena in these cells. The resemblance between M2-induced changes in cell shape to changes produced by 10 jaM-monensin (unpublished data), an ionophore known to substitute for M2 in regulating pH within the transport pathway (Sugrue et al., 1990a) , is consistent with this interpretation.
The assay of M2 activity in the reconstituted membrane system employed a K + gradient rather than a proton gradient, emulating the relationship between the cytoplasm (high [K+] ) and the trans Golgi compartment (high [Na+]). M2-and M2d-mediated proton fluxes (initial rates) were 46 times faster than fluxes into control vesicles. In view of the estimated purity of M2 and M2d proteins of 95 %, the presence of traces of other channelforming proteins cannot be excluded. However, the specific inhibition by low concentrations of rimantadine (0.1 to 1 jaM) and the drug resistance of the mutant protein M2d support the interpretation that the proton translocation activity was due to the viral protein.
In response to the K + diffusion potential and against the proton gradient, rimantadine and N-ethylrimantadine lowered the pH in protein-free control vesicles, which is consistent with the ability of the hydrochloride, not only the free base, to penetrate lipid bilayers (Duff et al., 1993) . The concentration ranges for the specific anti-M2 and non-specific effects of rimantadine were similar to those observed in virus-infected cells, where rimantadine, at 5 jaM and above, counteracts its own specific M2-mediated effect (maximum at 0.5 jaM) on trans Golgi pH . Other amphiphilic primary amines and weak bases have also been shown to act this way (Sugrue et al., 1990) .
Though proton influx is driven by the K + gradient, it makes only a minor contribution to the dissipation of this gradient. Whether, like M2 expressed in X. laevis oocytes (Pinto et al., 1992) , the M2 protein in the in vitro system is also capable of forming Na+-permeable channels is not known, since Na + influx was not monitored. Recent voltage-clamp studies have, however, indicated that the M2 protein expressed in mouse erythroleukaemia cells does form proton-selective channels (I. Chizmachov, F. Geraghty, D. Ogden & A. Hay, unpublished results) .
The data presented here are consistent with the ability of the M2 protein to promote proton translocation in vivo and with its two proposed roles in virus infection, acidification of the virion interior during uncoating and protection of HA against premature acid-induced conformational change during protein transport.
